$Zai Lab Ltd(ZLAB)$ is really

$Zai Lab Ltd(ZLAB)$ is really making moves! The sales of Weiwei Jia reached over $30 million, and in 2024, most of their revenue is expected to come from this drug—exciting times ahead!

Yesterday, they hit another major milestone with the acceptance of the listing application for tisotumab vedotin, developed in collaboration with Seagen, for the treatment of recurrent or metastatic cervical cancer.

The potential is huge! Continuing to stay bullish, looking forward to Zai Lab’s next big breakout!

Winning Trades

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":413464916243016,"tweetId":"413464916243016","gmtCreate":1741945779721,"gmtModify":1741945785664,"author":{"id":9000000000000165,"idStr":"9000000000000165","authorId":9000000000000165,"authorIdStr":"9000000000000165","name":"BruceBryant","avatar":"https://static.tigerbbs.com/f1d96cc78482af9af850d206fe587ad3","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":146,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/c2686cc0190c1e1929a228fd5b41edbf","width":"696","height":"1122"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/c2686cc0190c1e1929a228fd5b41edbf","width":"696","height":"1122"}],"html":"<html><head></head><body> <a data-mention-id=\"ZLAB\" class=\"teditor-mention\" data-mention-name=\"Zai Lab Ltd\" href=\"https://ttm.financial/S/ZLAB\">$Zai Lab Ltd(ZLAB)$</a> is really making moves! The sales of Weiwei Jia reached over $30 million, and in 2024, most of their revenue is expected to come from this drug—exciting times ahead! Yesterday, they hit another major milestone with the acceptance of the listing application for tisotumab vedotin, developed in collaboration with Seagen, for the treatment of recurrent or metastatic cervical cancer. The potential is huge! Continuing to stay bullish, looking forward to Zai Lab’s next big breakout!<img src=\"https://community-static.tradeup.com/news/c2686cc0190c1e1929a228fd5b41edbf\" tg-width=\"696\" tg-height=\"1122\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"ZLAB\" class=\"teditor-mention\" data-mention-name=\"Zai Lab Ltd\" href=\"https://ttm.financial/S/ZLAB\">$Zai Lab Ltd(ZLAB)$</a> is really making moves! The sales of Weiwei Jia reached over $30 million, and in 2024, most of their revenue is expected to come from this drug—exciting times ahead! Yesterday, they hit another major milestone with the acceptance of the listing application for tisotumab vedotin, developed in collaboration with Seagen, for the treatment of recurrent or metastatic cervical cancer. The potential is huge! Continuing to stay bullish, looking forward to Zai Lab’s next big breakout!<img src=\"https://community-static.tradeup.com/news/c2686cc0190c1e1929a228fd5b41edbf\" tg-width=\"696\" tg-height=\"1122\"></body></html>","text":"$Zai Lab Ltd(ZLAB)$ is really making moves! The sales of Weiwei Jia reached over $30 million, and in 2024, most of their revenue is expected to come from this drug—exciting times ahead! Yesterday, they hit another major milestone with the acceptance of the listing application for tisotumab vedotin, developed in collaboration with Seagen, for the treatment of recurrent or metastatic cervical cancer. The potential is huge! Continuing to stay bullish, looking forward to Zai Lab’s next big breakout!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/413464916243016","repostId":0,"isVote":1,"tweetType":1,"viewCount":0,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ZLAB","09688"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":423,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/413464916243016"}